ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

8 hedge funds and large institutions have $4.2M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.85M
Puts
$5K
Net Calls
Net Calls Change

Top Buyers

1
+$1.14M
2
+$944K
3
+$400K
4
Morgan Stanley
Morgan Stanley
New York
+$339K
5
Goldman Sachs
Goldman Sachs
New York
+$316K

Top Sellers

1
-$522K
2
-$383K
3
-$152K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.14M
2
$944K
3
$769K
4
$400K
5
$389K
6
$316K
7
$177K
8
$68K